Abstract
Purpose of Review
This comprehensive review covers the advantage and limitations of some dressing materials and the current knowledge on wound dressings and emerging technologies to achieve proper wound healing.
Recent Findings
Traditional and modern dressings are helpful in the wound healing process; however, they cannot substitute lost tissue. Human skin equivalents have been developed conceptually to fill this void as they do not only facilitate wound healing but also may replace lost tissue. Several studies have shown that the addition of mesenchymal stem cells, such as in human placenta, has promising results in wound healing.
Summary
A wound is defined as a disruption in the continuity of the skin or mucosa due to physical or thermal damage, or an underlying medical condition. Wound healing is a complex, dynamic, and multistep process which occurs after skin damage leading to tissue repair. Although the skin normally undergoes repair after a disruption, the healing process can be affected in different conditions such as diabetes mellitus, infections, venous/arterial insufficiency, among others. To enhance healing, a wide range of wound dressings are available; however, a thorough wound assessment (e.g., wound type, size, depth, or color) is required to choose the appropriate dressing. The emergence of new dressings has brought a new perspective of wound healing, but there is no superior product yet to treat acute and/or chronic wounds. Therefore, wound dressing research studies need to be carried out in order to help improve wound healing.
Similar content being viewed by others
Abbreviations
- DFU:
-
Diabetic foot ulcer
- dHACM:
-
Dehydrated human amnion/chorion membrane
- ECM:
-
Extracellular matrix
- EGF:
-
Epidermal growth factor
- FGF:
-
Fibroblast growth factor
- GM-CSF:
-
Granulocyte-macrophage colony-stimulating factor
- HA:
-
Hyaluronic acid
- HSE:
-
Human skin equivalents
- IGF-1:
-
Insulin-like growth factor
- MSC:
-
Mesenchymal stem cell
- PDGF:
-
Platelet-derived growth factor
- RCT:
-
Randomized control trial
- sNAG:
-
Shortened nanofibers of poly-N-acetyl glucosamine
- TGF-β1:
-
Transforming growth factor
- VLU:
-
Venous leg ulcer
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Boateng JS, Matthews KH, Stevens HN, Eccleston GM. Wound healing dressings and drug delivery systems: a review. J Pharm Sci. 2008;97(8):2892–923.
Dhivya S, Padma VV, Santhini E. Wound dressings—a review. Biomedicine (Taipei). 2015;5(4):22. Comprehensive review article that offers a critical discussion of several kinds of wound dressings.
Percival JN. Classification of wounds and their management. Surgery. 2002;20:114–7.
Moore K, McCallion R, Searle RJ, Stacey MC, Harding KG. Prediction and monitoring the therapeutic response of chronic dermal wounds. Int Wound J. 2006;3(2):89–96.
Landén NX, Li D, Ståhle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci. 2016;73(20):3861–85.
Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219–29.
Pereira RF, Bártolo PJ. Traditional therapies for skin wound healing. Adv Wound Care (New Rochelle). 2016;5(5):208–29.
Weller C, Sussman G. Wound dressings update. J Pharm Pract Res. 2006;36:318–24. Review article which covers a thorough description in wound assessment and different types of wound dressings.
Daunton C, Kothari S, Smith L, Steele D. A history of materials and practices for wound management. Wound Pract Res. 2012;20:174–86.
Shah JB. The history of wound care. J Am Col Certif Wound Spec. 2011;3(3):65–6.
Jones VJ. The use of gauze: will it ever change? Int Wound J. 2006;3(2):79–86.
Sung KY, Lee SY. Nonoperative management of extravasation injuries associated with neonatal parenteral nutrition using multiple punctures and a hydrocolloid dressing. Wounds. 2016;28(5):145–51.
Koksal C, Bozkurt AK. Combination of hydrocolloid dressing and medical compression stockings versus Unna’s Boot for the treatment of venous leg ulcers. Swiss Med Wkly. 2003;133(25–26):364–8.
Jiang Q, Zhou W, Wang J, Tang R, Zhang D, Wang X. Hypromellose succinate-crosslinked chitosan hydrogel films for potential wound dressing. Int J Biol Macromol. 2016;91:85–91.
Wichterle O, Lim D. Hydrophilic gels for biological use. Nature. 1960;185:117–8.
Jayakumar R, Rajkumar M, Freitas H, Selvamurugan N, Nair SV, Furuike T, et al. Preparation, characterization, bioactive and metal uptake studies of alginate/phosphorylated chitin blend films. Int J Biol Macromol. 2009;44(1):107–11.
Wang T, Qisheng G, Zhao J, Mei J, Shao M, Pan Y, et al. Calcium alginate enhances wound healing by up-regulating the ratio of collagen types I/III in diabetic rats. Int J Clin Exp Pathol. 2015;8(6):6636–45.
Balakrishnan B, Mohanty M, Umashankar PR, Jayakrishnan A. Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin. Biomaterials. 2005;26:6335–42.
Kurczewska J, Sawicka P, Ratajczak M, Gajęcka M, Schroeder G. Will the use of double barrier result in sustained release of vancomycin? Optimization of parameters for preparation of a new antibacterial alginate-based modern dressing. Int J Pharm. 2015;496(2):526–33.
Kuo CK, Ma PX. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties. Biomaterials. 2001;2(6):511–21.
Blair SD, Jarvis P, Salmon M, McCollum C. Clinical trial of calcium alginate haemostatic swabs. Br J Surg. 1990;77:568–70.
Blair SD, Backhouse CM, Harper R, Matthews J, McCollum CN. Comparison of absorbable materials for surgical haemostasis. Br J Surg. 1988;75:69–71.
Segal HC, Hunt BJ, Gilding K. The effects of alginate and non-alginate wound dressings on blood coagulation and platelet activation. J Biomater Appl. 1998;12:249–57.
Thomas A, Harding KG, Moore K. Alginates from wound dressings activate human macrophages to secrete tumor necrosis factor-alpha. Biomaterials. 2000;21(17):1797–802.
Schmidt RJ, Turner TD. Calcium alginate dressings. Pharm J. 1986;236:578.
Doyle JW, Roth T, Smith M. Effects of calcium alginate on cellular wound healing processes modelled in vitro. J Biomed Mater Res. 1996;32(4):561–8.
Morgan DA. Wounds: what should a dressing formulary include? Hosp Pharm. 2009;9:261–6.
Vermeulen H, Ubbink DT, Goossens A, de Vos R, Legemate DA. Systematic review of dressings and topical agents for surgical wounds healing by secondary intention. Br J Surg. 2005;92(6):665–72. Epidemiological study which highlights the differences between dressings and topical agents.
Ramos-e-Silva M, Ribeiro de Castro MC. New dressings, including tissue-engineered living skin. Clin Dermatol. 2002;20(6):715–23.
Ramshaw JA, Werkmeister JA, Glattauer V. Collagen-based biomaterials. Biotechnol Genet Eng Rev. 1996;13:335–82.
González A. Use of collagen extracellular matrix dressing for the treatment of a recurrent venous ulcer in a 52-year-old patient. J Wound Ostomy Continence Nurs. 2016;43(3):310–2.
Doillon CJ, Silver FH. Collagen-based wound dressing: effects of hyaluronic acid and fibronectin on wound healing. Biomaterials. 1986;7(1):3–8.
Lee M, Han SH, Choi WJ, Chung KH, Lee JW. Hyaluronic acid dressing (Healoderm) in the treatment of diabetic foot ulcer: a prospective, randomized, placebo-controlled, single-center study. Wound Repair Regen. 2016;24(3):581–8.
Ferrari R, Boracchi P, Romussi S, Ravasio G, Stefanello D. Application of hyaluronic acid in the healing of non-experimental open wounds: a pilot study on 12 wounds in 10 client-owned dogs. Vet World. 2015;8(10):1247–59.
Ishihara M, Nakanishi K, Ono K, Sato M, Kikuchi M, Saito Y, et al. Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials. 2002;23(3):833–40.
Abdel-Mohsen AM, Jancar J, Massoud D, Fohlerova Z, Elhadidy H, Spotz Z, et al. Novel chitin/chitosan-glucan wound dressing: isolation, characterization, antibacterial activity and wound healing properties. Int J Pharm. 2016;510(1):86–99.
Anjum S, Arora A, Alam MS, Gupta B. Development of antimicrobial and scar preventive chitosan hydrogel wound dressings. Int J Pharm. 2016;508(1–2):92–101.
Fan X, Chen K, He X, Li N, Huang J, Tang K, et al. Nano-TiO2/collagen-chitosan porous scaffold for wound repairing. Int J Biol Macromol. 2016;91:15–22.
Choi SM, Ryu HA, Lee KM, Kim HJ, Park IK, Cho WJ, et al. Development of stabilized growth factor-loaded hyaluronate-collagen dressing (HCD) matrix for impaired wound healing. Biomater Res. 2016;20:9.
Catanzano O, D’Esposito V, Acierno S, Ambrosio MR, De Caro C, Avagliano C, et al. Alginate-hyaluronan composite hydrogels accelerate wound healing process. Carbohydr Polym. 2015;131:407–14.
Mian M, Beghè F, Mian E. Collagen as a pharmacological approach in wound healing. Int J Tissue React. 1992;14(Suppl):1–9.
Ruszczak Z, Friess W. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv Drug Deliv Rev. 2003;55(12):1679–98.
Dreifke MB, Jayasuriya AA, Jayasuriya AC. Current wound healing procedures and potential care. Mater Sci Eng C Mater Biol Appl. 2015;48:651–62. Analytical review of wound dressings based on biocompatible polymers.
Dreifke MB, Ebraheim NA, Jayasuriya AC. Investigation of potential injectable polymeric biomaterials for bone regeneration. J Biomed Mater Res A. 2013;101(8):2436–47.
Turley EA, Torrance J. Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibroblasts. Exp Cell Res. 1985;161(1):17–28.
Moczar M, Robert L. Stimulation of cell proliferation by hyaluronidase during in vitro aging of human skin fibroblasts. Exp Gerontol. 1993;28(1):59–68.
Ghazi K, Deng-Pichon U, Warnet JM, Rat P. Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: role of molecular weight. PLoS One. 2012;7(11):e48351.
Abdel-Mohsen AM, Jancar J, Massoud D, Fohlerova Z, Elhadidy H, Spotz Z, Hebeish A. Novel chitin/chitosan-glucan wound dressing: Isolation, characterization, antibacterial activity and wound healing properties. Int J Pharm. 2016;510(1):86–99.
Ueno H, Mori T, Fujinaga T. Topical formulations and wound healing applications of chitosan. Adv Drug Deliv Rev. 2001;52(2):105–15.
Moura LI, Dias AM, Leal EC, Carvalho L, de Sousa HC, Carvalho E. Chitosan-based dressings loaded with neurotensin—an efficient strategy to improve early diabetic wound healing. Acta Biomater. 2014;10(2):843–57.
Kirichenko AK, Bolshakov IN, Ali-Riza AE, Vlasov AA. Morphological study of burn wound healing with the use of collagen-chitosan wound dressing. Bull Exp Biol Med. 2013;154(5):692–6.
Choi JS, Kim JD, Yoon HS, Cho YW. Full-thickness skin wound healing using human placenta-derived extracellular matrix containing bioactive molecules. Tissue Eng Part A. 2013;19(3–4):329–39.
Wojtowicz AM, Oliveira S, Carlson MW, Zawadzka A, Rousseau CF, Baksh D. The importance of both fibroblasts and keratinocytes in a bilayered living cellular construct used in wound healing. Wound Repair Regen. 2014;22(2):246–55.
Nathoo R, Howe N, Cohen G. Skin substitutes: an overview of the key players in wound management. J Clin Aesthet Dermatol. 2014;7(10):44–8.
Centanni JM, Straseski JA, Wicks A, et al. StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial. Ann Surg. 2011;253(4):672–83.
Sun T, Han Y, Chai J, Yang H. Transplantation of microskin autografts with overlaid selectively decellularized split thickness porcine skin in the repair of deep burn wounds. J Burn Care Res. 2011;32(3):e67–73.
Marston WA, Hanft J, Norwood P, Pollak R, Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers, results of a prospective randomized trial. Diabetes Care. 2003;26(6):1701–5.
Límová M. Active wound coverings: bioengineered skin and dermal substitutes. Surg Clin North Am. 2010;90(6):1237–55.
Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999;7(4):201–7.
Marston WA, Sabolinski ML, Parsons NB, Kirsner RS. Comparative effectiveness of a bilayered living cellular construct and a porcine collagen wound dressing in the treatment of venous leg ulcers. Wound Repair Regen. 2014;22(3):334–40.
Falabella AF, Valencia IC, Eaglstein WH, Schachner LA. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol. 2000;136(10):1225–30.
Muhart M, McFalls S, Kirsner RS, Elgart GW, Kerdel F, Sabolinski ML, et al. Behavior of tissue-engineered skin: a comparison of a living skin equivalent, autograft, and occlusive dressing in human donor sites. Arch Dermatol. 1999;135(8):913–8.
Mathur M, De A, Gore M. Microbiological assessment of cadaver skin grafts received in a Skin Bank. Burns. 2009;35(1):104–6.
Brigido SA. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. Int Wound J. 2006;3(3):181–7.
González Alaña I, Torrero López JV, Martín Playá P, Gabilondo Zubizarreta FJ. Combined use of negative pressure wound therapy and Integra® to treat complex defects in lower extremities after burns. Ann Burns Fire Disasters. 2013;26(2):90–3.
Park CA, Defranzo AJ, Marks MW, Molnar JA. Outpatient reconstruction using Integra and sub atmospheric pressure. Ann Plast Surg. 2009;62(2):164–9.
Molnar JA, DeFranzo AJ, Hadaegh A, Morykwas MJ, Shen P, Argenta LC. Acceleration of Integra incorporation in complex tissue defects with sub atmospheric pressure. Plast Reconstr Surg. 2004;113(5):1339–46.
Raimer DW, Group AR, Petitt MS, Nosrati N, Yamazaki ML, Davis NA, et al. Porcine xenograft biosynthetic wound dressings for the management of postoperative Mohs wounds. Dermatol Online J. 2011;17(9):1.
Romanelli M, Dini V, Bertone MS. Randomized comparison of OASIS wound matrix versus moist wound dressing in the treatment of difficult-to-heal wounds of mixed arterial/venous etiology. Adv Skin Wound Care. 2010;23(1):34–8.
Mostow EN, Haraway GD, Dalsing M, Hodde JP, King D, OASIS Venus Ulcer Study Group. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg. 2005;41(5):837–43. One of the first papers to show the effectiveness of this graft in VLUs. This paper may have increased the frequency of using this graft for VLUs treatment.
Palmer BL, Gantt DS, Lawrence ME, Rajab MH, Dehmer GJ. Effectiveness and safety of manual hemostasis facilitated by the SyvekPatch with one hour of bedrest after coronary angiography using six-French catheters. Am J Cardiol. 2004;93(1):96–7.
Lindner HB, Zhang A, Eldridge J, Demcheva M, Tsichlis P, et al. Anti-bacterial effects of poly-N-acetyl-glucosamine nanofibers in cutaneous wound healing: requirement for Akt1. PLoS One. 2011;6(4):e18996.
Pietramaggiori G, Yang HJ, Scherer SS, Kaipainen A, Chan RK, et al. Effects of poly-N-acetyl glucosamine (pGlcNAc) patch on wound healing in db/db mouse. J Trauma. 2008;64(3):803–8.
Scherer SS, Pietramaggiori G, Matthews J, Perry S, Assmann A, et al. Poly-N-acetyl glucosamine nanofibers: a new bioactive material to enhance diabetic wound healing by cell migration and angiogenesis. Ann Surg. 2009;250(2):322–30.
Kelechi TJ, Mueller M, Hankin CS, Bronstone A, Samies J, et al. A randomized, investigator-blinded, controlled pilot study to evaluate the safety and efficacy of a poly-N-acetyl glucosamine-derived membrane material in patients with venous leg ulcers. J Am Acad Dermatol. 2012;66(6):e209–15.
Maxson S, Lopez EA, Yoo D, Danilkovitch-Miagkova A, Leroux MA. Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med. 2012;1(2):142–9.
Shin L, Peterson DA. Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells. Stem Cells Transl Med. 2013;2(1):33–42.
Faulk WP, Matthews R, Stevens PJ, Bennett JP, Burgos H, et al. Human amnion as an adjunct in wound healing. Lancet. 1980;1:1156–8.
Gibbons GW. Grafix®, a cryopreserved placental membrane, for the treatment of chronic/stalled wounds. Adv Wound Care (New Rochelle). 2015;4(9):534–44.
Lavery LA, Fulmer J, Shebetka KA, et al. The efficacy and safety of Grafix((R)) for the treatment of chronic diabetic foot ulcers: results of a multicentre, controlled, randomized, blinded, clinical trial. Int Wound J. 2014;11:554–60. Seminal study which demonstrates this graft as a good option for DFUs. This paper may have expanded this graft use to other pathologies.
Regulski M, Jacobstein DA, Petranto RD, Migliori VJ, Nair G, et al. A retrospective analysis of a human cellular repair matrix for the treatment of chronic wounds. Ostomy Wound Manage. 2013;59:38–43.
Zelen CM, Serena TE, Denoziere G, Fetterolf DE. A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers. Int Wound J. 2013;10(5):502–7.
Fetterolf DE, Istwan NB, Stanziano GJ. An evaluation of healing metrics associated with commonly used advanced wound care products for the treatment of chronic diabetic foot ulcers. Manag Care. 2014;23:31–8.
Zelen CM, Gould L, Serena TE, Carter MJ, Keller J, Li WW. A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers. Int Wound J. 2015;12(6):724–32.
Amin N, Doupis J. Diabetic foot disease: from the evaluation of the “foot at risk” to the novel diabetic ulcer treatment modalities. World J Diabetes. 2016;7(7):153–64.
Phaechamud T, Issarayungyuen P, Pichayakorn W. Gentamicin sulfate-loaded porous natural rubber films for wound dressing. Int J Biol Macromol. 2016;85:634–44.
Meaume S, Vallet D, Morere MN, Téot L. Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care. 2005;14(9):411–9.
Denkbaş EB, Oztürk E, Ozdemir N, Keçeci K, Agalar C. Norfloxacin-loaded chitosan sponges as wound dressing material. J Biomater Appl. 2004;18(4):291–303.
Aoyagi S, Onishi H, Machida Y. Novel chitosan wound dressing loaded with minocycline for the treatment of severe burn wounds. Int J Pharm. 2007;330(1–2):138–45.
Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YH. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol. 2008;74(7):2171–8.
Komarcević A. The modern approach to wound treatment. Med Pregl. 2000;53(7–8):363–8 [Article in Croatian].
Huang G, Sun T, Zhang L, Wu Q, Zhang K, Tian Q, et al. Combined application of alginate dressing and human granulocyte-macrophage colony stimulating factor promotes healing in refractory chronic skin ulcers. Exp Ther Med. 2014;7(6):1772–6.
Yan H, Chen J, Peng X. Recombinant human granulocyte-macrophage colony-stimulating factor hydrogel promotes healing of deep partial thickness burn wounds. Burns. 2012;38(6):877–81.
Da Costa RM, Ribeiro Jesus FM, Aniceto C, Mendes M. Randomized, double-blind, placebo-controlled, dose-ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers. Wound Repair Regen. 1999;7(1):17–25.
Khanbanha N, Atyabi F, Taheri A, Talaie F, Mahbod M, Dinarvand R. Healing efficacy of an EGF impregnated triple gel based wound dressing: in vitro and in vivo studies. Biomed Res Int. 2014;2014:493732.
Shi L, Ermis R, Kiedaisch B, Carson D. The effect of various wound dressings on the activity of debriding enzymes. Adv Skin Wound Care. 2010;23(10):456–62.
Ramundo J, Gray M. Enzymatic wound debridement. J Wound Ostomy Continence Nurs. 2008;35:273–80.
Miller JD, Carter E, Hatch DC, Zhubrak M, Giovinco NA, Armstrong DG. Use of collagenase ointment in conjunction with negative pressure wound therapy in the care of diabetic wounds: a case series of six patients. Diabet Foot Ankle. 2015;6:24999.
Singh D, Singh R. Papain incorporated chitin dressings for wound debridement sterilized by gamma radiation. Radiat Phys Chem. 2012;81:1781–5.
Mustafah NM, Chung TY. Papase as a treatment option for the overgranulating wound. J Wound Care. 2014;23(2 Suppl):S10–2.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Luis J. Borda and Flor E. Macquhae declare that they have no conflicts of interest to disclose.
Dr. Kirsner reports grants from Smith and Nephew, personal fees from Organogenesis, outside the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Wound Care and Healing
Rights and permissions
About this article
Cite this article
Borda, L.J., Macquhae, F.E. & Kirsner, R.S. Wound Dressings: A Comprehensive Review. Curr Derm Rep 5, 287–297 (2016). https://doi.org/10.1007/s13671-016-0162-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13671-016-0162-5